Reference
Tostes FT, et al. Response to Pembrolizumab in Advanced Anal Squamous Cell Carcinoma With High TMB and PD-L1 and PD-L2 Amplification. Clinical Colorectal Cancer 20: 350-353, No. 4, Dec 2021. Available from: URL: http://www.journals.elsevier.com/clinical-colorectal-cancer
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1934, 50 (2022). https://doi.org/10.1007/s40278-022-28431-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-28431-0